BridgeMD
New treatment option for Nutrition Intervention
Official title Optimizing Early Nutrition Management of Extremely and/or Very Preterm Infants
ClinicalTrials.gov ID: NCT07538999
What this study is testing
What is A nutritional improving bundle for the intervention group?
A nutritional improving bundle for the intervention group is an investigational medicine, being studied as a potential treatment for nutrition intervention.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- A clinical quality improvement bundle on early nutrition supplementation is developed to improving the clinical outcomes (including growth, organ function, and neurodevelopment outcomes) of extremely and/or very preterm infants. This bundle consists of three aspects: individualized and precise human milk feeding, early enteral zinc supplementation, and routine parenteral carnitine supplementation.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages up to 1
You may be able to join if
- for intervention group:
- (1) Admitted to the Neonatal Department of Children's Hospital of Fudan University during the study period.
- (2) Preterm infants with a gestational age \< 32 weeks or a birth weight \< 1500 g.
- (3) Admitted to the study center within 24 hours after birth.
- (4) Obtained informed consent from family members.
You likely can't join if
- for intervention group
- (1) Newborns with severe congenital diseases, severe congenital malformations, chromosomal abnormalities, or genetic metabolic diseases.
- (2) Death or discharge within two weeks after birth. Inclusion Criteria for control group:
- (1) Admitted to the Neonatal Department of Children's Hospital of Fudan University from January 2025 to December 2025.
- (2) Preterm infants with a gestational age \< 32 weeks or a birth weight \< 1500 g.
- (3) Admitted to the study center within 24 hours after birth. Exclusion Criteria for control group
See the full eligibility criteria
- for intervention group:
- (1) Admitted to the Neonatal Department of Children's Hospital of Fudan University during the study period.
- (2) Preterm infants with a gestational age \< 32 weeks or a birth weight \< 1500 g.
- (3) Admitted to the study center within 24 hours after birth.
- (4) Obtained informed consent from family members.
- for intervention group
- (1) Newborns with severe congenital diseases, severe congenital malformations, chromosomal abnormalities, or genetic metabolic diseases.
- (2) Death or discharge within two weeks after birth. Inclusion Criteria for control group:
- (1) Admitted to the Neonatal Department of Children's Hospital of Fudan University from January 2025 to December 2025.
- (2) Preterm infants with a gestational age \< 32 weeks or a birth weight \< 1500 g.
- (3) Admitted to the study center within 24 hours after birth. Exclusion Criteria for control group
- (1) Newborns with severe congenital diseases, severe congenital malformations, chromosomal abnormalities, or genetic metabolic diseases.
- (2) Death or discharge within two weeks after birth.
The study team makes the final eligibility decision.
Where it's taking place
- Shanghai, China
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, up to 1 day. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Shanghai, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.